Corbus Pharmaceuticals Holdings, Inc. Public Float
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Public Float of $67.80 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $67.80M.
- 2024-06-30: Entity Public Float $428.00M.
- 2023-06-30: Entity Public Float $34.57M.
- 2022-06-30: Entity Public Float $31.48M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $67.80M 10-K · filed 2026-03-09 |
| 2024-06-30 | $428.00M 10-K · filed 2025-03-11 |
| 2023-06-30 | $34.57M 10-K/A · filed 2024-03-20 |
| 2022-06-30 | $31.48M 10-K · filed 2023-03-07 |
| 2021-12-31 | $201.86M 10-K · filed 2022-03-08 |
| 2020-06-30 | $664.54M 10-K · filed 2021-03-15 |
| 2019-06-30 | $390.13M 10-K · filed 2020-03-16 |
| 2018-06-30 | $271.27M 10-K · filed 2019-03-12 |
| 2017-06-30 | $294.88M 10-K · filed 2018-03-12 |
| 2016-06-30 | $121.54M 10-K · filed 2017-03-08 |
| 2015-06-30 | $72.83M 10-K · filed 2016-03-28 |
| 2015-02-02 | $39.38M 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |